Safe Surf Rated - www.safesurf.com Back To Home Page Family Friendly Site - www.familyfriendlysites.com
About
Bradford
  HIV/AIDS
Articles
  Alternative
Therapies
  HIV/AIDS
Videos
  HIV/AIDS
Links
  HIV/AIDS
News

Introduction:
Positively Positive
- Living with HIV
  Out
About
HIV
  Resume/
Curriculum Vitae:
HIV / AIDS Involvements
  Biography   HIV/AIDS
News Archive
HIV and AIDS News spacer.gif Bradford McIntyre spacer.gif
spacer.gif
   
AIDS Awareness Red Ribbon


Modeling the global HIV treatment funding gap for 2020 targets

PLOS

24-Nov-2015 - With currently projected funding, countries around the world are unlikely to achieve the Joint United Nations Programme on HIV/AIDS 90-90-90 treatment target (which includes 90% of people diagnosed as living with HIV being treated with anti-retroviral therapy (ART) by 2020), according to a modeling study publishing this week in PLOS Medicine . The study, conducted by Arin Dutta and colleagues at Palladium, Washington, District of Columbia, U.S., suggests that while the funding gap may be smaller than previously projected, meeting the 90-90-90 target will require currently unsecured funding for the broad adoption of a test-and-offer approach and other measures to rapidly increase ART coverage.

The researchers estimated annual numbers of people eligible for and receiving ART treatment under three scenarios: countries' current eligibility criteria for treatment, the World Health Organization (WHO) 2013 eligibility criteria, and expanded eligibility to meet the WHO 2015 guidelines and the 90-90-90 targets. In these simulations, the estimated gap over six years between the resources needed for ART scale-up and the domestic and external financial resources available ranged from US$19.8 billion to US$25.0 billion depending on the scenario and the level of financial support provided by PEPFAR (the U.S. President's Emergency Plan for AIDS Relief) and the Global Fund to Fight AIDS, Tuberculosis and Malaria.

The study analysis is novel in considering all facility-level costs of delivering this life-saving intervention at a global scale for countries with significant HIV epidemics, incorporating predictions on shift in epidemics as well as in the costs of medicines and diagnostic supplies. The accuracy of this study's findings may be limited by the quality of country- and region-specific data, assumptions about available funding, and the fact that only the facility-level costs of ART provision were considered. Nonetheless, the predictions broadly suggest that additional resources must be made available through domestic or external financing sources or efficiency gains. The authors state, "As the world moves towards adopting the WHO 2015 guidelines, advances in technology, including the introduction of lower-cost, highly effective antiretroviral regimens ... may prove to be 'game changers' that allow more people to be on ART with the resources available."

###

Research Article

Funding:

The U.S. Agency for International Development (USAID) funded this work through the Health Policy Project. The Health Policy Project is a five-year cooperative agreement funded by USAID under Agreement No. AID-OAA-A-10-00067, beginning September 30, 2010. The project's HIV activities are supported by USAID and the President's Emergency Plan for AIDS Relief (PEPFAR). The project is implemented by Palladium, in collaboration with Plan International USA, Avenir Health, Partners in Population and Development, Africa Regional Office (PPD ARO), Population Reference Bureau (PRB), RTI International, and the White Ribbon Alliance for Safe Motherhood (WRA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

The authors have declared that no competing interests exist.

Citation:

Dutta A, Barker C, Kallarakal A (2015) The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020. PLoS Med 12(11): e1001907. doi:10.1371/journal.pmed.1001907

Author Affiliations:

Palladium, Washington, District of Columbia, United States of America

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://journals. plos. org/ plosmedicine/ article?id= 10. 1371/ journal. pmed. 1001907

Contact:

Arin Dutta
Senior Economist
Palladium
1331 Pennsylvania Avenue NW
Suite 600
United States
Washington DC, District of Columbia 20004
UNITED STATES
+1-202-777-0956
Arin.Dutta@thepalladiumgroup.com


Source: http://www.eurekalert.org/pub_releases/2015-11/p-mtg111315.php


For more HIV and AIDS News visit...

Positively Positive - Living with HIV/AIDS:
HIV/AIDS News


...positive attitudes are not simply 'moods'

Site Map

Contact Bradford McIntyre.

Web Design by Trevor Uksik
uks.jpg

Copyright © 2003-2017 Bradford McIntyre. All rights reserved.

DESIGNED TO CREATE HIV & AIDS AWARENESS

spacer.gif